3 Hrs
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
3 Hrsالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
3 HrsReady to play
Ready to play
A small study involving 14 patients found that baxdrostat, which inhibits the production of the hormone aldosterone, lowered blood pressure associated with primary aldosteronism. The improvement lasted for up to two years after patients stopped taking the drug. About a quarter of participants were able to stop all their blood-pressure medications while keeping their blood pressure normal, but researchers stressed that the findings are preliminary and that a larger trial is underway to confirm them. Primary aldosteronism is estimated to be associated with about 5 to 10 percent of cases of high blood pressure.
Notice: This Is an AI-Generated Summary
Comments (0)